Myeloablative radioimmunotherapy in conditioning prior to haematological stem cell transplantation: Closing the gap between benefit and toxicity?

Medicine and Dentistry

• Conditioning 100%
• Radioimmunotherapy 100%
• Drug Megadose 40%
• Pentetic Acid 40%
• Monoclonal Antibody 40%
• Radioactive Tracer 20%
• Combination Therapy 20%
• Individualization 20%
• Reduced Intensity Conditioning 20%
• Myeloablative Conditioning 20%
• Comorbidity 20%
• Yttrium 90 20%
• Antileukemic Agent 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Monoclonal Antibody 100%
• Tracer 50%
• Antileukemic Agent 50%
• Yttrium 90 50%
• Combination Therapy 50%
• Comorbidity 50%

Immunology and Microbiology

• Monoclonal Antibody 66%
• Drug Megadose 66%
• Autologous Hematopoietic Stem Cell Transplantation 33%
• Comorbidity 33%